• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[巴西里约热内卢一家大学医院老年肺结核患者的治疗分析]

[Analysis of the treatment of pulmonary tuberculosis in elderly patients at a university hospital in Rio de Janeiro, Brazil].

作者信息

Cantalice Filho João Paulo, Bóia Márcio Neves, Sant Anna Clemax Couto

机构信息

Instituto de Doenças do Tórax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.

出版信息

J Bras Pneumol. 2007 Nov-Dec;33(6):691-8. doi: 10.1590/s1806-37132007000600013.

DOI:10.1590/s1806-37132007000600013
PMID:18200370
Abstract

OBJECTIVE

To describe the clinical and therapeutic aspects of pulmonary tuberculosis and compare the adverse effects of the treatment and its outcome in elderly and nonelderly patients.

METHODS

This was a case-control study of 117 elderly individuals (over the age of 60 years) and 464 nonelderly individuals (aged 15-49 years). All subjects presented pulmonary tuberculosis that had been diagnosed and treated at the Thoracic Diseases Institute of the Federal University of Rio de Janeiro between 1980 and 1996.

RESULTS

In the elderly group, pulmonary tuberculosis was found to be correlated with diabetes (OR = 3.98; 95% CI = 2.07-7.65; p = 0.001), lung disease (OR = 7.24; 95% CI = 3.64-14.46; p = 0.001) and heart disease (OR = 5.86; 95% CI = 2.88-11.95; p = 0.001). Smoking (OR = 2.07; 95% CI = 1.26-3.42; p = 0.002) and alcohol abuse (OR = 1.63; 95% CI = 1.01-2.68; p = 0.041) were also more common in the elderly group. In the elderly group, the treatment more frequently resulted in adverse reactions (OR = 1.62; 95% CI = 1.04-2.54; p = 0.024), especially gastrointestinal reactions (OR = 1.64; 95% CI = 1.01-2.77; p = 0.047), and treatment efficacy was lower: cure rate, 51%; mortality rate, 24%. Treatment adherence was low (approximately 77%) in both groups.

CONCLUSIONS

In the elderly group, adverse reactions were more common, treatment outcomes were less favorable, there was a greater frequency of clinical complications and deaths related to drug toxicity, and the prevalence of concomitant diseases was higher.

摘要

目的

描述肺结核的临床和治疗方面,并比较老年患者和非老年患者治疗的不良反应及其结果。

方法

这是一项病例对照研究,纳入了117名老年个体(年龄超过60岁)和464名非老年个体(年龄15 - 49岁)。所有受试者均患有肺结核,于1980年至1996年期间在里约热内卢联邦大学胸科疾病研究所被诊断并接受治疗。

结果

在老年组中,发现肺结核与糖尿病(比值比[OR]=3.98;95%置信区间[CI]=2.07 - 7.65;p = 0.001)、肺部疾病(OR = 7.24;95% CI = 3.64 - 14.46;p = 0.001)和心脏病(OR = 5.86;95% CI = 2.88 - 11.95;p = 0.001)相关。吸烟(OR = 2.07;95% CI = 1.26 - 3.42;p = 0.002)和酗酒(OR = 1.63;95% CI = 1.01 - 2.68;p = 0.041)在老年组中也更常见。在老年组中,治疗更常导致不良反应(OR = 1.62;95% CI = 1.04 - 2.54;p = 0.024),尤其是胃肠道反应(OR = 1.64;95% CI = 1.01 - 2.77;p = 0.047),且治疗效果较低:治愈率为51%;死亡率为24%。两组的治疗依从性均较低(约77%)。

结论

在老年组中,不良反应更常见,治疗结果较差,与药物毒性相关的临床并发症和死亡频率更高,且合并疾病的患病率更高。

相似文献

1
[Analysis of the treatment of pulmonary tuberculosis in elderly patients at a university hospital in Rio de Janeiro, Brazil].[巴西里约热内卢一家大学医院老年肺结核患者的治疗分析]
J Bras Pneumol. 2007 Nov-Dec;33(6):691-8. doi: 10.1590/s1806-37132007000600013.
2
Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.利福平与吡嗪酰胺用于治疗潜伏性结核感染的安全性。
Expert Opin Drug Saf. 2004 May;3(3):187-98. doi: 10.1517/eods.3.3.187.31073.
3
Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.利福平加吡嗪酰胺与异烟肼治疗潜伏性结核感染的比较:一项荟萃分析。
Int J Tuberc Lung Dis. 2006 Oct;10(10):1080-90.
4
Clinical treatment outcomes of tuberculosis treated with the basic regimen recommended by the Brazilian National Ministry of Health using fixed-dose combination tablets in the greater metropolitan area of Goiânia, Brazil.巴西戈亚尼亚大都市区采用巴西国家卫生部推荐的基本方案并用固定剂量复合片剂治疗结核病的临床治疗效果。
J Bras Pneumol. 2013 Jan-Feb;39(1):76-83. doi: 10.1590/s1806-37132013000100011.
5
Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.利福平与异烟肼治疗潜伏性结核的依从性改善及毒性降低:一项回顾性研究
Arch Intern Med. 2006 Sep 25;166(17):1863-70. doi: 10.1001/archinte.166.17.1863.
6
[Clinical aspects of pulmonary tuberculosis in elderly patients from a university hospital in Rio de Janeiro, Brazil].[巴西里约热内卢一家大学医院老年患者肺结核的临床特征]
J Bras Pneumol. 2007 Nov-Dec;33(6):699-706. doi: 10.1590/s1806-37132007000600014.
7
Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity.吡嗪酰胺和利福平与异烟肼治疗潜伏性结核:完成率提高但肝毒性更大。
Chest. 2003 Jan;123(1):102-6. doi: 10.1378/chest.123.1.102.
8
The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide.采用含利福平、异烟肼和吡嗪酰胺方案治疗的高龄老年肺结核患者的临床结局。
Clin Interv Aging. 2016 Mar 11;11:299-306. doi: 10.2147/CIA.S95411. eCollection 2016.
9
Death associated with rifampin and pyrazinamide 2-month treatment of latent mycobacterium tuberculosis.与利福平及吡嗪酰胺治疗潜伏性结核分枝杆菌2个月相关的死亡
Chest. 2002 May;121(5):1710-2. doi: 10.1378/chest.121.5.1710.
10
Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment.利福平-吡嗪酰胺及异烟肼预防性治疗和结核病治疗的肝毒性
Clin Infect Dis. 2004 Aug 15;39(4):488-96. doi: 10.1086/422645. Epub 2004 Jul 30.

引用本文的文献

1
Treatment outcomes and associated influencing factors among elderly patients with rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study in China.老年耐利福平肺结核患者的治疗结局及相关影响因素:一项中国的多中心、回顾性队列研究
BMC Infect Dis. 2025 Sep 1;25(1):1086. doi: 10.1186/s12879-025-11491-4.
2
Structural model of determinants of medication adherence in elderly individuals with tuberculosis in Iran.伊朗老年结核病患者药物依从性决定因素的结构模型
BMC Public Health. 2025 Aug 18;25(1):2828. doi: 10.1186/s12889-025-23727-8.
3
The possible impact of socioeconomic, income, and educational status on adverse effects of drug and their therapeutic episodes in patients targeted with a combination of tuberculosis interventions.
社会经济、收入和教育状况对接受多种结核病干预措施的患者药物不良反应及其治疗过程的潜在影响。
Saudi J Biol Sci. 2021 Apr;28(4):2041-2048. doi: 10.1016/j.sjbs.2021.02.004. Epub 2021 Feb 14.
4
Primary Drug-Resistance Pattern and Trend in Elderly Tuberculosis Patients in Shandong, China, from 2004 to 2019.2004年至2019年中国山东省老年结核病患者的原发性耐药模式及趋势
Infect Drug Resist. 2020 Nov 13;13:4133-4145. doi: 10.2147/IDR.S277203. eCollection 2020.
5
Characteristics and risk factors associated with missed diagnosis in patients with smear-negative pulmonary tuberculosis.与涂片阴性肺结核患者漏诊相关的特征和危险因素。
Korean J Intern Med. 2021 Mar;36(Suppl 1):S151-S159. doi: 10.3904/kjim.2019.435. Epub 2020 Aug 20.
6
Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs.一线抗结核药物的药物不良反应发生率及作用机制
Saudi Pharm J. 2020 Mar;28(3):316-324. doi: 10.1016/j.jsps.2020.01.011. Epub 2020 Jan 31.
7
APACHE-II score for anti-tuberculosis tolerance in critically ill patients: a retrospective study.急性生理学与慢性健康状况评分系统Ⅱ对重症结核病患者耐结核治疗的预测价值:一项回顾性研究。
BMC Infect Dis. 2019 Feb 4;19(1):106. doi: 10.1186/s12879-019-3751-7.
8
Risk factors associated with adverse reactions to antituberculosis drugs.与抗结核药物不良反应相关的危险因素。
J Bras Pneumol. 2015 Jan-Feb;41(1):77-89. doi: 10.1590/S1806-37132015000100010.
9
Profile and treatment outcomes of tuberculosis in the elderly in southeastern Nigeria, 2011-2012.2011 - 2012年尼日利亚东南部老年人结核病概况及治疗结果
PLoS One. 2014 Nov 4;9(11):e111910. doi: 10.1371/journal.pone.0111910. eCollection 2014.
10
Population aging and migrant workers: bottlenecks in tuberculosis control in rural China.人口老龄化和农民工:中国农村结核病控制的瓶颈。
PLoS One. 2014 Feb 3;9(2):e88290. doi: 10.1371/journal.pone.0088290. eCollection 2014.